title: Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis.
abstract: Poststroke hyperglycaemia (PSH) is common, has an unclear pathophysiology, and is associated with poor outcomes. Animal studies report conflicting findings. We systematically reviewed the effects of hyperglycaemia on infarct volume in middle cerebral artery occlusion (MCAO) models, generating weighted mean differences between groups using random effects models summarised as effect size (normalised to control group infarct volume as 100%) and 95% confidence interval. Of 72 relevant papers, 23 reported infarct volume. Studies involved 664 animals and 35 distinct comparisons. Hyperglycaemia was induced by either streptozotocin (STZ, 17 comparisons, n=303) or dextrose (18 comparisons, n=356). Hyperglycaemic animals had infarcts that were 94% larger, but STZ was associated with significantly greater increase in infarct volumes than dextrose infusion (140% larger versus 48% larger). In seven studies, insulin did not significantly reduce infarct size and results were heterogeneous. Although hyperglycaemia exacerbates infarct volume in MCAO models, studies are heterogeneous, and do not address the common clinical problem of PSH because they have used either the STZ model of type I diabetes or extremely high glucose loads. Insulin had a nonsignificant and significantly heterogeneous effect. Further studies with relevant models may inform clinical trial design.
authors.affiliation: Institute of Neuroscience & Psychology, Southern General Hospital, University of Glasgow, Glasgow, Scotland, UK.
authors.forename: Niall J J
authors.initials: NJ
authors.lastname: MacDougall
authors.forename: Keith W
authors.initials: KW
authors.lastname: Muir
mesh_terms: D000818:Animals; D002544:Cerebral Infarction / Q000150:complications* / Q000209:etiology / Q000473:pathology*; D005947:Glucose; D006943:Hyperglycemia / Q000139:chemically induced / Q000150:complications*; D007004:Hypoglycemic Agents / Q000494:pharmacology; D020244:Infarction, Middle Cerebral Artery / Q000150:complications*; D007328:Insulin / Q000494:pharmacology; D013311:Streptozocin
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D013311:Streptozocin; D005947:Glucose